Pure Global

“CIMA” BiVisc Sodium Hyaluronate/Sodium Chondroitin Sulfate Ophthalmic Viscosurgical Device - Taiwan Registration da18b373a688adc1beab8e012d0bdab7

Access comprehensive regulatory information for “CIMA” BiVisc Sodium Hyaluronate/Sodium Chondroitin Sulfate Ophthalmic Viscosurgical Device in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number da18b373a688adc1beab8e012d0bdab7 and manufactured by CIMA Technology Inc.. The authorized representative in Taiwan is COSMOS BIO, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
da18b373a688adc1beab8e012d0bdab7
Registration Details
Taiwan FDA Registration: da18b373a688adc1beab8e012d0bdab7
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“CIMA” BiVisc Sodium Hyaluronate/Sodium Chondroitin Sulfate Ophthalmic Viscosurgical Device
TW: “西瑪”雙維視人工眼內黏彈性溶液
Risk Class 3
MD

Registration Details

da18b373a688adc1beab8e012d0bdab7

Ministry of Health Medical Device Import No. 033897

DHA05603389707

Company Information

United States

Product Details

For details, it is Chinese approved copy of the imitation order

M Ophthalmic devices

M4275 Liquid for intraocular filling

Imported from abroad

Dates and Status

Aug 25, 2020

Aug 25, 2025